SCHEMBL7984682

SCHEMBL7984682

O=c1nc(-c2cccc(O)c2)[nH]c2ncn(Cc3ccccc3F)c12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 3/20 0.39
PDE4B Q07343 3/20 0.39
PDE4C Q08493 3/20 0.39
PDE4D Q08499 3/20 0.39
TP53 P04637 2/20 0.38
HSD17B13 Q7Z5P4 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 2/20 0.37
POLB P06746 1/20 0.37
LCK P06239 1/20 0.36
BTK Q06187 1/20 0.36
MAPK14 Q16539 1/20 0.36
PTPN1 P18031 1/20 0.36
PARN O95453 1/20 0.36
CNOT7 Q9UIV1 1/20 0.36
MKNK1 Q9BUB5 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36
PDE5A O76074 1/20 0.36
PDE1A P54750 1/20 0.36
PDE1B Q01064 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988753 0.90 ACP1 (0.41) PDE4APDE4BPDE4CPDE4DTP53
SCHEMBL7985415 0.89 ALDH1A1 (0.39) PDE4APDE4BPDE4CPDE4DTP53
SCHEMBL7987224 0.88 LMNA (0.44) PDE4APDE4BPDE4CPDE4DTP53
SCHEMBL7974203 0.88 ACP1 (0.41) PDE4APDE4BPDE4CPDE4DTP53
SCHEMBL7985342 0.85 CNOT7 (0.51) ALDH1A1PTPN1PARNCNOT7
SCHEMBL7988416 0.85 ALDH1A1 (0.49) ALDH1A1P2RX7
SCHEMBL7985619 0.85 CNOT7 (0.41) HSD17B13ALDH1A1LMNAMAPK14PARN
SCHEMBL7986760 0.84 ALDH1A1 (0.41) PDE4APDE4BPDE4CPDE4DTP53
SCHEMBL7984677 0.84 TP53 (0.41) PDE4APDE4BPDE4CPDE4DTP53
SCHEMBL7991638 0.84 GRIN1 (0.42) HSD17B13PARNCNOT7MKNK1MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed